Cited by 402Dementia and Cognitive Impairment ResearchBlood Pressure and Hypertension StudiesNeurological Disease Mechanisms and Treatments

Blood Pressure and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 209 Prospective Studies

Ou, Ya-Nan, Tan, Chen-Chen, Shen, Xue-Ning, Xu, Wei, Hou, Xiao-He, Dong, Qiang, Tan, Lan, Yu, Jin-Tai·2020·Hypertension

Abstract

Controversies persist regarding the association between blood pressure (BP) and the risks of cognitive impairment and dementia due to inconsistent definitions of BP exposure and varying population characteristics. Here, we searched PubMed and performed a meta-analysis of the influence of BP exposure on the risks of cognitive disorders in prospective studies. Dose-response analyses were performed to illustrate the existence of linear/nonlinear relationships. The credibility of each meta-analysis was evaluated according to the risk of bias, inconsistency, and imprecision. Of the 31 628 citations, 209 were included in our systematic review, among which 136 were eligible for the meta-analysis. Overall, stronger associations were found in midlife than late-life. Moderate-quality evidence indicated that midlife hypertension was related to a 1.19- to 1.55-fold excess risk of cognitive disorders. Dose-response analyses of 5 studies indicated that midlife systolic BP >130 mm Hg was associated with an increased risk of cognitive disorders. With regard to BP exposure in late-life, high systolic BP, low diastolic BP, excessive BP variability, and orthostatic hypotension were all associated with an increased dementia risk. Encouragingly, the use of antihypertensive medications exhibited a 21% reduction in dementia risk. The U-shaped dose-response curve indicated that the protective window of diastolic BP level was between 90 and 100 mm Hg for low risk of Alzheimer disease. The relationships between BP variables and cognitive disorders are age- and BP type-dependent. Antihypertensive medications were associated with a reduced risk of dementia. However, the optimal dose, duration, and type for preventing cognitive disorders warrant further investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.120.14993

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ou, Y.-N., Tan, C.-C., Shen, X.-N., Xu, W., Hou, X.-H., Dong, Q., Tan, L., & Yu, J.-T.
Affiliations
  • Qingdao University (CN)
  • Shanghai Medical College of Fudan University (CN)
Corresponding author
  • Ou, Ya-Nan
  • Tan, Chen-Chen
Venue
Hypertension
Published
2020-07
Volume
76
Issue
1
Pages
217-225
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W3032784914
Cited by
402
References
35
Citations by year
2026: 61 · 2025: 87 · 2024: 87 · 2023: 78 · 2022: 52 · 2021: 33 · 2020: 4
FWCI
30.46
Type
journal article
Language
en
Open access
closed
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
Fudan University
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
blood pressure, cognitive impairment, dementia, Alzheimer's disease, midlife blood pressure, systolic blood pressure, diastolic blood pressure, blood pressure variability, orthostatic hypotension, antihypertensive drugs, dose-response relationship, U-shaped curve, dementia risk
MeSH terms
Adult, Age Factors, Aged, Alzheimer Disease, Antihypertensive Agents, Blood Pressure, Cognition Disorders, Dementia, Follow-Up Studies, Humans, Hypertension, Hypotension, Orthostatic, Middle Aged, Prospective Studies, Risk, Comorbidity, Causality, Least-Squares Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review